Ultra high performance liquid chromatography-tandem mass spectrometry method for cyclosporine a quantification in biological samples and lipid nanosystems

被引:18
作者
Guada, M. [1 ]
Imbuluzqueta, E. [1 ]
Estella-Hermoso de Mendoza, A. [1 ]
Lana, H. [1 ]
Dios-Vieitez, M. C. [1 ]
Blanco-Prieto, M. J. [1 ]
机构
[1] Univ Navarra, Sch Pharm, Dept Pharm & Pharmaceut Technol, E-31008 Pamplona, Spain
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2013年 / 927卷
关键词
Cyclosporine A; UHPLC-tandem mass spectrometry; Lipid nanocarriers; Pharmacokinetics; Biodistribution; HUMAN WHOLE-BLOOD; IMMUNOSUPPRESSIVE DRUGS; TRANSPLANT RECIPIENTS; METABOLITES AM1; NANOPARTICLES; HPLC; IMMUNOASSAYS; TACROLIMUS; PLASMA; AM4N;
D O I
10.1016/j.jchromb.2013.02.001
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Cyclosporine A (CyA) is an immunosuppressant cyclic undecapeptide used for the prevention of organ transplant rejection and in the treatment of several autoimmune disorders. An ultra high performance liquid chromatography tandem mass spectrometry method (UHPLC-MS/MS) to quantify CyA in lipid nanosystems and mouse biological matrices (whole blood, kidneys, lungs, spleen, liver, heart, brain, stomach and intestine) was developed and fully validated. Chromatographic separation was performed on an Acquity UPLC (R) BEH C18 column with a gradient elution consisting of methanol and 2 mM ammonium acetate aqueous solution containing 0.1% formic acid at a flow rate of 0.6 mL/min. Amiodarone was used as internal standard (IS). Retention times of IS and CyA were 0.69 min and 1.09 min, respectively. Mass spectrometer operated in electrospray ionization positive mode (ESI+) and multiple reaction monitoring (MRM) transitions were detected, m/z 1220.69 -> 1203.7 for CyA and m/z 646 -> 58 for IS. The extraction method from biological samples consisted of a simple protein precipitation with 10% trichloroacetic acid aqueous solution and acetonitrile and 5 mu L of supernatant were directly injected into the UHPLC-MS/MS system. Linearity was observed between 0.001 mu g/mL-2.5 mu g/mL (r >= 0.99) in all matrices. The precision expressed in coefficient of variation (CV) was below 11.44% and accuracy in bias ranged from -12.78% to 7.99% including methanol and biological matrices. Recovery in all cases was above 70.54% and some matrix effect was observed. CyA was found to be stable in post-extraction whole blood and liver homogenate samples exposed for 6h at room temperature and 72 h at 4 degrees C. The present method was successfully applied for quality control of lipid nanocarriers as well as in vivo studies in BALB/c mice. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:164 / 172
页数:9
相关论文
共 34 条
[1]   Simple determination of cyclosporine in human whole blood by high-performance liquid chromatography [J].
Amini, H ;
Ahmadiani, A .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2003, 795 (02) :209-214
[2]   Quantification of cyclosporine and tacrolimus in whole blood. Comparison of liquid chromatography-electrospray mass spectrometry with the enzyme multiplied immunoassay technique [J].
Ansermot, Nicolas ;
Fathi, Marc ;
Veuthey, Jean-Luc ;
Desmeules, Jules ;
Rudaz, Serge ;
Hochstrasser, Denis .
CLINICAL BIOCHEMISTRY, 2008, 41 (10-11) :910-913
[3]   Simultaneous LC-MS-MS determination of cyclosporine A, tacrolimus, and sirolimus in whole blood as well as mycophenolic acid in plasma using common pretreatment procedure [J].
Bogusz, Maciej J. ;
Al Enazi, Eid ;
Hassan, Huda ;
Abdel-Jawaad, Jamil ;
Al Ruwaily, Jamal ;
Al Tufail, Mohammed .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 850 (1-2) :471-480
[4]   Liquid chromatography-tandem mass spectrometry method for simultaneous determination of cyclosporine A and its three metabolites AM1, AM9 and AM4N in whole blood and isolated lymphocytes in renal transplant patients [J].
Brozmanova, Hana ;
Perinova, Ilona ;
Halvova, Petra ;
Grundmann, Milan .
JOURNAL OF SEPARATION SCIENCE, 2010, 33 (15) :2287-2293
[5]   Comparison of different cyclosporine immunoassays to monitor C0 and C2 blood levels from kidney transplant recipients:: Not simply overestimation [J].
Cattaneo, D ;
Zenoni, S ;
Murgia, B ;
Merlini, S ;
Baldelli, S ;
Perico, N ;
Gotti, E ;
Ottomano, C ;
Crippa, A ;
Remuzzi, G .
CLINICA CHIMICA ACTA, 2005, 355 (1-2) :153-164
[6]   In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma [J].
de Mendoza, Ander Estella-Hermoso ;
Preart, Veronique ;
Mollinedo, Faustino ;
Blanco-Prieto, Maria J. .
JOURNAL OF CONTROLLED RELEASE, 2011, 156 (03) :421-426
[7]   Liquid chromatography/mass spectrometry for therapeutic drug monitoring of immunosuppressants [J].
Deters, M ;
Kaever, V ;
Kirchner, GI .
ANALYTICA CHIMICA ACTA, 2003, 492 (1-2) :133-145
[8]   Solid lipid nanoparticles: an oral bioavailability enhancer vehicle [J].
Harde, Harshad ;
Das, Manasmita ;
Jain, Sanyog .
EXPERT OPINION ON DRUG DELIVERY, 2011, 8 (11) :1407-1424
[9]   Simultaneous measurement of cyclosporin A and tacrolimus from dried blood spots by ultra high performance liquid chromatography tandem mass spectrometry [J].
Hinchliffe, Edward ;
Adaway, Joanne E. ;
Keevil, Brian G. .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2012, 883 :102-107
[10]   Increasing speed and throughput when using HPLC-MS/MS systems for drug metabolism and pharmacokinetic screening [J].
Hsieh, Yunsheng ;
Korfmacher, Walter A. .
CURRENT DRUG METABOLISM, 2006, 7 (05) :479-489